2m 2m 2m 2m 2m 2m 2m
CONTEXT THERAP (CNTX)
NASDAQ
$0.64-$0.008 (-1.18%)
Price as of Jun 23, 2026 7:49 PM EDT- $57.9MMarket Cap
- 13.18%1-Year Change
- BiotechnologyIndustry
CONTEXT THERAP (CNTX)
$0.64-$0.008 (-1.18%)
CNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.65 | ||
Change | +$0.02 (+3.46%) | ||
Open | $0.60 | ||
High | $0.70 | ||
Low | $0.59 | ||
Previous Close | $0.63 | ||
Volume | 3,189,153 | ||
30-Day Average Volume | 2,706,949 | ||
1-Week Change | 0.22% | ||
1-Month Change | -74.93% | ||
1-Year Change | 13.18% | ||
3-Year Change | -51.37% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 91.9M | ||
Total Assets | $58.9M | ||
Market Cap | $57.9M | ||
Enterprise Value | $3.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.7M | ||
Free Cash Flow | -$11.5M | ||
EBIT | -$8.7M | ||
EBITDA | -$8.7M | ||
Net Working Capital | $52.0M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue